wada aod9604 prohibited list 2025 just added tirzepatide (mounjaro) to the 2026 Monitoring Program Illegal and falsified medicines self-administrated

Mitochondrial function is improving, which shows up as better energy and exercise capacity

In laboratory studies, AOD9604 has been shown to promote lipolysis (breakdown of stored fat) in cultured adipocytes (fat cells) and influence the expression of genes related to fat metabolism

More specifically, IV infusions and/or injections of any substance in excess of 100 mL per 12-hour period are prohibited at all times , except for those legitimately received in the course of hospital treatment, surgical procedures, or clinical diagnostic investigations

(, ):

Consult with your healthcare provider to determine if this product is right for you